Clinical Trials Directory

Trials / Conditions / Pneumococcal Immunization

Pneumococcal Immunization

8 registered clinical trials studyying Pneumococcal Immunization — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingLot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of
NCT07348692
SanofiPhase 3
RecruitingA Study to Learn More About Prevenar 20 Once it is Out in the Korean Market
NCT06760208
Pfizer—
Active Not RecruitingStudy of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
NCT06975878
SanofiPhase 3
Active Not RecruitingStudy of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococ
NCT06824181
SanofiPhase 3
Active Not RecruitingStudy of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Mont
NCT06824194
SanofiPhase 3
Active Not RecruitingStudy of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately
NCT06736041
Sanofi Pasteur, a Sanofi CompanyPhase 3
CompletedStudy of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years.
NCT04583618
SanofiPhase 2
CompletedSafety and Immunogenicity of a Pneumococcal Conjugate Vaccine Candidate in Healthy Adults (19-49 Years)
NCT06698198
Sanofi Pasteur, a Sanofi CompanyPhase 1